Read + Share
Amedeo Smart
Independent Medical Education
Speicher T, Burgard C, Bastian M, Rosar F, et al. First Successful In-Human Application of 225Ac-DOTA-LM3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3). Clin Nucl Med 2025;50:101-102.PMID: 39626292
Email
LinkedIn
Privacy Policy